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Colorectal cancer in primary care
Even with national screening, primary care can do more to cut mortality
Primary care has a substantial role in reducingthe public health burden of colorectal cancer.Given that mortality from colorectal cancer
increases with more advanced disease at diagnosis1 and
that most patients present with symptoms that
prompted them to consult their general practitioner,2
both patients and doctors need to recognise the symp-
toms that suggest a high risk of cancer.
In this week’s BMJ du Toit and colleagues report a
10 year prospective study which confirms the
importance of rectal bleeding as an indicative
symptom for colorectal cancer.3 The study found that
about one in 10 patients with new onset rectal bleeding
had cancer. The authors say that general practitioners
should investigate anyone aged 45 years and older who
presents with rectal bleeding, with or without a change
in bowel habit.
Lower gastrointestinal symptoms are common in
general practice but largely non-specific,4 and general
practitioners face considerable challenges in determin-
ing which symptoms warrant urgent attention. The
evidence on rectal bleeding varies according to the
setting and design of studies, and treating all cases as
potential colorectal cancer may lead to many unneces-
sary investigations.5
Yet current patterns of practice need to change. We
know, for example, that standard guidance is insufficient
to ensure the best use of urgent referrals.6 A promising
development is the use of diagnostic algorithms based
on symptom scores, which can guide clinicians in inter-
preting various combinations of symptoms and patients’
characteristics.7 These techniques need refining using
data from primary care populations that have not been
referred to specialists. We also urgently need studies
examining whether incorporating estimates of quantita-
tive risk into decision making on cancer referral can
work—in the same way that estimating cardiovascular
risk is now routine in primary care.
To reduce the future burden from colorectal cancer,
primary care must engage with a range of strategies
beyond symptom based early diagnosis. The UK
government has decided to introduce screening in Eng-
land based on the faecal occult blood test. Evidence sup-
porting screening for bowel cancer is convincing,8 and
the UK pilot study has shown that screening is feasible in
the general population, with acceptable rates of uptake
and detection.9 The programme is being rolled out
(albeit more slowly than expected10), and recruitment
and follow-up will be organised centrally, although some
of the workload (such as meeting patients’ information
needs) will spill over to primary care.11 Other countries
such as Australia are similarly committed,12 though with
less central coordination. The US government favours
an unregulated approach in which screening by faecal
occult blood testing is often bypassed for more definitive
tests such as colonoscopy.13
In England general practitioners will need to
correct patients’ misunderstandings about bowel
cancer and to emphasise the low sensitivity of the
faecal occult blood test. The programme in England is
targeting 60-69 year olds initially (based largely on
arguments of cost effectiveness and higher yield).
Those working in primary care will inevitably deal with
patients on either side of this narrow age window
asking about symptoms and requesting screening, and
will probably field more inquiries about dietary factors
such as fibre and fruit consumption.14 Furthermore,
ongoing effort will be required to maintain participa-
tion rates close to 60%, and this will be strongly
influenced by information received in primary care.11
Perhaps most importantly, many people invited for
screening will have symptoms, and they may believe
that taking a screening test precludes the need to have
those symptoms investigated further. On the contrary,
rigorous symptom based diagnosis will still be vital in
reducing rates of missed and interval cancers, and can-
cers in non-participants.
The paper by du Toit and colleagues3 adds to a
growing body of evidence that we need to investigate
new onset rectal bleeding effectively. Further studies
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should refine existing guidance on rectal bleeding and
other gastrointestinal symptoms. Consideration of the
specific characteristics of rectal bleeding may, for
example, have the potential to improve the sensitivity
and specificity of referral to specialist care.14
A consistent message from available evidence is
that general practitioners should treat rectal bleeding
with a high index of suspicion, take into account other
factors related to patients and not be distracted by the
presence of haemorrhoids or other pathology unre-
lated to cancer. They will also have an increasingly
important role in educating patients about responding
to symptoms in the context of a screening programme.
David Weller professor of general practice, University of
Edinburgh
(david.weller@ed.ac.uk)
Division of Community Health Sciences, University of Edinburgh,
Edinburgh EH10 5PF
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Support for young people with diabetes
Reducing psychological distress may improve metabolic control
The prevalence in Europe of insulin dependent(type 1) diabetes in children by age 15 is about3 per 1000 and rising at roughly 2-5 % yearly.1
This complex and chronic illness interferes with almost
every aspect of day to day life and can be a
considerable burden for the child and the family.
Therapeutic goals include “promotion of optimal
health, social wellbeing and quality of life for all
diabetic children around the world.”2
Living with diabetes entails continuous daily atten-
tion to a complex array of management options,
including insulin administration and dose adjustments
around variable meals and exercise, blood glucose
monitoring and its interpretation, maintaining a
healthy diet, and understanding the need for early
detection of both acute and long term complications.
This is daunting for many young people. In this week’s
BMJ Winkley and colleagues report a meta-analysis of
one approach to helping these young people: psycho-
logical interventions for managing glycaemic control.3
Satisfactory metabolic control as measured by
glycated haemoglobin may prevent long term microvas-
cular and macrovascular complications. The studies pro-
viding evidence for this emphasise the importance of
successful intensified treatment.4 Regimens comprising
multiple dose injections of insulin before meals and
bedtime more closely mimic normal patterns of insulin
secretion than conventional regimens of one or two
injections daily and, if used appropriately, can maintain
near normal blood glucose values. Newer analogue
insulins, sophisticated insulin pumps, and continuous
blood glucose monitoring systems are changing the face
of insulin management in young people.
But intensified treatment places greater demands
on the patient and the family. A curriculum of
appropriate education at the onset of diabetes and
over time can show patients and families how to adjust
insulin dosages for variations in food intake and exer-
cise, parties, holidays, sick days, and other different life
events. Knowledge alone, though, does not necessarily
improve adherence to treatment, and this is particu-
larly true during adolescence.5 6 w1-w3
Why does metabolic outcome in children and even
more so in adolescents remain, at best, suboptimal in
many centres, despite technical and therapeutic
improvements?w4 And why does metabolic control vary
so much between children as well as between centres,
despite attempts to implement basic standards for the
care of children with diabetes, including the use of spe-
cialised multidisciplinary teams?7 8
The biggest study in adolescents with diabetes
showed that better metabolic control may be associated
with improved quality of life, whereas poorer metabolic
control is associated with anxiety, depression, low self
esteem, and fears about diabetes.9 Moreover, poor
initial psychological adjustment in children and
adolescents is linked to poorer long term outcome of
diabetes,10 while family cohesion is associated with
better long term outcome.11
In their meta-analysis in this week’s BMJ Winkley
and colleagues report that psychological interventions
in childhood have a positive but weak effect on
metabolic control in diabetes, a finding that has not been
shown in studies in adults.3 Importantly, the beneficial
effect on the psychological distress of the children and
their families was strong and significant. Randomised
controlled trials included in this systematic review had
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